Have your own idea? Try our Stock Screener
U.S. Healthcare Sector Analysis
UpdatedNov 29, 2024
DataAggregated Company Financials
Companies1400
- 7D2.0%
- 3M-5.5%
- 1Y12.1%
- YTD5.6%
Eli Lilly is up 4.6%, leading the way for the Healthcare industry, which has gained 3.0%. In the last 12 months, the industry was up 14%. Earnings are forecast to grow by 22% annually.
Sector Valuation and Performance
Has the U.S. Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 29 Nov 2024 | US$6.2t | US$2.9t | US$77.3b | 28.5x | 79.6x | 2.1x |
| Sun, 27 Oct 2024 | US$6.0t | US$2.8t | US$59.1b | 29.1x | 102.2x | 2.1x |
| Tue, 24 Sep 2024 | US$6.3t | US$2.8t | US$60.1b | 30.1x | 104.6x | 2.2x |
| Thu, 22 Aug 2024 | US$6.2t | US$2.8t | US$56.2b | 32x | 110.6x | 2.2x |
| Sat, 20 Jul 2024 | US$6.3t | US$2.8t | US$60.8b | 31.7x | 103.2x | 2.2x |
| Mon, 17 Jun 2024 | US$6.2t | US$2.8t | US$62.5b | 30x | 98.9x | 2.2x |
| Wed, 15 May 2024 | US$6.1t | US$2.8t | US$63.7b | 30.8x | 96x | 2.2x |
| Fri, 12 Apr 2024 | US$6.1t | US$2.8t | US$85.4b | 32.1x | 71.4x | 2.2x |
| Sun, 10 Mar 2024 | US$6.3t | US$2.8t | US$85.3b | 32.5x | 73.8x | 2.3x |
| Tue, 06 Feb 2024 | US$6.2t | US$2.8t | US$83.9b | 31.4x | 74.5x | 2.2x |
| Thu, 04 Jan 2024 | US$6.3t | US$2.8t | US$90.2b | 31.6x | 69.7x | 2.2x |
| Sat, 02 Dec 2023 | US$5.9t | US$2.8t | US$91.4b | 28.8x | 64.5x | 2.1x |
| Mon, 30 Oct 2023 | US$5.5t | US$2.8t | US$99.5b | 24.1x | 55.6x | 2x |
| Wed, 27 Sep 2023 | US$5.9t | US$2.8t | US$98.5b | 27.4x | 59.8x | 2.1x |
| Fri, 25 Aug 2023 | US$6.1t | US$2.8t | US$99.0b | 27.8x | 61.3x | 2.2x |
| Sun, 23 Jul 2023 | US$6.2t | US$2.7t | US$110.9b | 26.9x | 55.5x | 2.2x |
| Tue, 20 Jun 2023 | US$6.0t | US$2.7t | US$109.9b | 26.4x | 54.8x | 2.2x |
| Thu, 18 May 2023 | US$6.0t | US$2.7t | US$111.0b | 23.9x | 53.6x | 2.2x |
| Sat, 15 Apr 2023 | US$6.0t | US$2.5t | US$123.8b | 24.2x | 48.3x | 2.4x |
| Mon, 13 Mar 2023 | US$5.5t | US$2.5t | US$122.9b | 23.9x | 44.9x | 2.2x |
| Wed, 08 Feb 2023 | US$6.0t | US$2.5t | US$132.4b | 23.8x | 45.2x | 2.4x |
| Fri, 06 Jan 2023 | US$6.0t | US$2.5t | US$135.4b | 22.6x | 44.1x | 2.4x |
| Sun, 04 Dec 2022 | US$6.2t | US$2.4t | US$133.7b | 24.1x | 46.2x | 2.5x |
| Tue, 01 Nov 2022 | US$5.9t | US$2.4t | US$149.0b | 23.1x | 39.6x | 2.4x |
| Thu, 29 Sep 2022 | US$5.6t | US$2.4t | US$155.9b | 21.1x | 35.9x | 2.3x |
| Sat, 27 Aug 2022 | US$5.8t | US$2.4t | US$157.1b | 22.9x | 36.9x | 2.4x |
| Mon, 25 Jul 2022 | US$5.9t | US$2.6t | US$164.6b | 24.9x | 35.9x | 2.3x |
| Wed, 22 Jun 2022 | US$5.5t | US$2.6t | US$165.4b | 23x | 33.4x | 2.1x |
| Fri, 20 May 2022 | US$5.7t | US$2.6t | US$165.0b | 25.6x | 34.7x | 2.2x |
| Sun, 17 Apr 2022 | US$6.5t | US$2.5t | US$175.4b | 29x | 37x | 2.6x |
| Tue, 15 Mar 2022 | US$6.1t | US$2.5t | US$170.7b | 27.1x | 35.6x | 2.5x |
| Thu, 10 Feb 2022 | US$6.4t | US$2.5t | US$165.5b | 30.4x | 38.8x | 2.6x |
| Sat, 08 Jan 2022 | US$6.5t | US$2.4t | US$145.2b | 31.5x | 44.9x | 2.7x |
| Mon, 06 Dec 2021 | US$6.5t | US$2.4t | US$146.5b | 30x | 44.2x | 2.7x |
Price to Earnings Ratio
44.2x
Current Industry PE
- Investors are optimistic on the American Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 79.4x which is higher than its 3-year average PE of 59.6x.
- The industry is trading close to its 3-year average PS ratio of 2.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 19% per year over the last three years.
- Meanwhile revenues for these companies have grown 6.8% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the U.S. Healthcare sector?
| US Market | 0.49% | |
| Healthcare | 2.00% | |
| Healthtech | 4.92% | |
| Pharma | 2.64% | |
| Biotech | 2.40% | |
| Healthcare Services | 1.95% | |
| Life Sciences | 1.94% | |
| Medical Equipment | 0.77% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 56.4x.
- Analysts are expecting annual earnings growth of 18.8%, which is higher than its past year's earnings decline of 4.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 31% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Medical Equipment industry is expected to see its earnings grow by 17% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| LLY Eli Lilly | US$788.19 | 5.4% +US$36.2b | 35.0% | PE84.8x | |
| UNH UnitedHealth Group | US$608.38 | 3.0% +US$16.1b | 11.2% | PE39.1x | |
| ABBV AbbVie | US$183.08 | 3.5% +US$10.8b | 27.7% | PE63.7x | |
| MRK Merck | US$103.12 | 4.0% +US$10.0b | -0.3% | PE21.5x | |
| VRTX Vertex Pharmaceuticals | US$464.56 | 3.0% +US$3.5b | 32.3% | PS11.3x |
